Real-world outcomes in patients with metastatic renal cell carcinoma according to risk factors: the STAR-TOR registry | Future Oncology
Active surveillance in metastatic renal-cell carcinoma: a prospective, phase 2 trial - The Lancet Oncology
EAU 2021: Evolving Landscape of First-Line Systemic Treatment in Metastatic Renal Cell Carcinoma
Kaplan-Meier curve depicting the overall survival of 359 metastatic... | Download Scientific Diagram
Treatment patterns and clinical outcomes in patients with renal cell carcinoma in the UK: insights from the RECCORD registry - Annals of Oncology
Thumbnails — IMDC | International mRCC Database Consortium
Clinical characteristics and prognosis of patients with renal cell carcinoma and liver metastasis
Real-world outcomes in patients with metastatic renal cell carcinoma according to risk factors: the STAR-TOR registry | Future Oncology
Safety and efficacy of nivolumab in combination with sunitinib or pazopanib in advanced or metastatic renal cell carcinoma: the CheckMate 016 study | Journal for ImmunoTherapy of Cancer | Full Text
Pazopanib versus Sunitinib in Metastatic Renal-Cell Carcinoma | NEJM
Five-year overall survival curves of renal cell carcinoma patients... | Download Scientific Diagram
Long-term follow-up of overall survival for cabozantinib versus everolimus in advanced renal cell carcinoma | British Journal of Cancer
Survival after complete surgical resection of multiple metastases from renal cell carcinoma - Alt - 2011 - Cancer - Wiley Online Library
Overall Survival in Renal-Cell Carcinoma with Pazopanib versus Sunitinib | NEJM
Prognostic Impact of Bone Metastasis on Survival Outcomes in Patients with Metastatic Renal Cell Carcinoma Treated by First Line Tyrosine Kinase Inhibitors: A Propensity-Score Matching Analysis
Frontiers | Survival in Metastatic Renal Cell Carcinoma Patients Treated With Sunitinib With or Without Cryoablation
Survival after Cytoreductive Nephrectomy in Metastatic Non-clear Cell Renal Cell Carcinoma Patients: A Population-based Study - European Urology Focus
Overall survival rates of 95 patients with metastatic renal cell... | Download Scientific Diagram
Frontiers | Do Metastatic Kidney Cancer Patients Benefit From Cytoreductive Nephrectomy? A Real-World Retrospective Study From the SEER Database
xmlinkhub
Validation of the GRade, Age, Nodes and Tumor (GRANT) score within the Surveillance Epidemiology and End Results (SEER) database: A new tool to predict survival in surgically treated renal cell carcinoma patients
Kaplan–Meier curves depicting overall survival (OS; a, b) and... | Download Scientific Diagram
Overall survival for patients with progressive metastatic renal cell... | Download Scientific Diagram
Overall survival of 180 patients with metastatic renal cell carcinoma... | Download Scientific Diagram
Renal Cell Cancer Treatment (PDQ®)–Health Professional Version - NCI
